Vivos Therapeutics Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

2.65

-0.08 (-2.93%)

At close: May 02, 2025, 12:46 PM

Vivos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	6.26M	1.64M	3.52M	24.03M	18.21M	469.35K	1.25M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	810.63K	785.06K	n/a
Other Long-Term Assets	216K	307K	374K	356K	1.12M	1.07M	26.91K
Receivables	430K	202K	457K	1.72M	1.52M	955.99K	595.19K
Inventory	n/a	n/a	n/a	n/a	1.00	263.81K	1.00
Other Current Assets	783K	616K	1.45M	n/a	673.06K	263.81K	133.93K
Total Current Assets	7.47M	2.46M	5.42M	27.32M	20.39M	1.98M	2.01M
Property-Plant & Equipment	4.38M	4.7M	4.78M	2.83M	871.6K	1.14M	1.28M
Goodwill & Intangibles	3.21M	3.26M	3.15M	3.18M	2.94M	3.36M	4.88M
Total Long-Term Assets	7.81M	8.27M	8.3M	6.37M	4.93M	5.57M	6.19M
Total Assets	15.28M	10.73M	13.72M	33.69M	25.33M	7.55M	8.2M
Account Payables	1.1M	2.15M	1.41M	920K	781K	1.08M	474.08K
Deferred Revenue	n/a	2.14M	2.93M	2.4M	2.94M	2.95M	889.51K
Short-Term Debt	477K	836K	419K	1.26M	866.97K	3.71M	161.54K
Other Current Liabilities	3.4M	1.03M	280K	1.46M	85.00	n/a	n/a
Total Current Liabilities	4.98M	7.29M	6.81M	7.51M	7.82M	9.09M	2.16M
Long-Term Debt	n/a	n/a	n/a	298K	423.1K	n/a	525K
Other Long-Term Liabilities	2.35M	1.22M	n/a	343K	163.97K	1.4M	695.02K
Total Long-Term Liabilities	2.35M	3.03M	2.11M	641K	587.06K	1.4M	1.22M
Total Liabilities	7.33M	10.32M	8.92M	8.15M	8.41M	10.49M	3.38M
Total Debt	1.51M	2M	2.41M	1.63M	1.29M	3.71M	686.54K
Common Stock	n/a	n/a	2K	2K	1.82K	1.24K	1.21K
Retained Earnings	-104.19M	-93.05M	-79.47M	-55.62M	-35.33M	-23.28M	-12.52M
Comprehensive Income	n/a	n/a	n/a	0.00	-1.5M	-1.32M	-666.67K
Shareholders Equity	7.95M	411K	4.8M	25.54M	16.92M	-2.94M	4.83M
Total Investments	n/a	n/a	n/a	n/a	810.63K	785.06K	n/a